Send me a link:

*Text messaging rates may apply.

 Dow Down 0.28% Nasdaq Down 0.17%

Ambit Biosciences Corporation (AMBI)

-NasdaqGM
5.30 0.05(0.95%) Jul 21, 4:00PM EDT
Prev Close:5.25
Open:5.25
Bid:5.25 x 100
Ask:5.80 x 500
1y Target Est:14.75
Beta:8.733
Earnings Date:Aug 11 - Aug 15 (Est.)
Day's Range:5.08 - 5.36
52wk Range:4.80 - 21.44
Volume:25,921
Avg Vol (3m):57,379
Market Cap:95.26M
P/E (ttm):N/A
EPS (ttm):-0.68
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for AMBI

Comparison

Symbol% ChgMkt Cap
AMBIUp 0.95%95.26M
BAYRY111.21B
ONXXN/A
PFE193.59B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4.60
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.29
Quarterly EPS Est (Jun-14) :-0.58
Mean Recommendation*:1.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Ambit Biosciences Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of oncology, autoimmune, and inflammatory diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback